# A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone

> **NCT06104878** · — · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06104878
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12-31
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision after projects re-evaluation, taken before the study initiation
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06104878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06104878, "A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06104878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*